In my opinion, Saturn doesn’t owe anyone anything for the Nortil having minimal effects. This is not a Saturn Meds-specific issue. It seems to be across the board regardless of vendor.
Coming here and acting like Saturns Meds somehow is liable to refund them because they purchase a brand new batch of a brand new RC, with next to no user reports (up until VERY recently), are being completely unreasonable. There’s got to be a level of accountability that is assumed. This is not something well researched with an accepted profile of effects, like 0D$MT for example.
At the end of the day, you’re buying a brand new Research Chem. Risks like this come with the territory, plain and simple. Even results from one batch to the next can differ exponentially (ex: pre-2024 4-Me-TMP vs post-2024 ‘citrus’ 4-Me-TMP). Tolerance to other mags of the same or similar genre also come into play and make it increasingly difficult to know if it’s a batch issue, product issue, or user issue.
If someone doesn’t want to risk buying a less than stellar product, then wait a few months until there’s some consensus on the efficacy and dose range.
However. I do applaud Saturn for their customer service and being so open to hearing their clientele out and inviting feedback both positive and negative alike.
-MB